Erratum to: Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study (Intern Emerg Med, (2014), 9, (861-870), DOI 10.1007/s11739-014-1096-1);Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study

Internal and Emergency Medicine

Volumn 9, Issue 8, 2014, Pages 861-870

  Raparelli, Valeria ^a   Proietti, Marco ^a   Buttà, Carmelo ^b   Di Giosia, Paolo ^c   Sirico, Domenico ^d   Gobbi, Paolo ^e   Corrao, Salvatore ^b   Davì, Giovanni ^f   Vestri, Anna Rita ^a   Perticone, Francesco ^g   Corazza, Gino Roberto ^e   Violi, Francesco ^a   Basili, Stefania ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e UNIVERSITY OF PAVIA   (Italy)

^f UNIVERSITY OF CHIETI   (Italy)

^g UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Antithrombotics; Drugs prescription; Geographical differences; Medication adherence; Non valvular atrial fibrillation; Socioeconomic status

Indexed keywords

ANTICOAGULANT AGENT;

AGED; ANKLE BRACHIAL INDEX; ATRIAL FIBRILLATION; CROSS-SECTIONAL STUDY; FEMALE; HEALTH CARE DISPARITY; HUMAN; ITALY; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; RISK FACTOR; SOCIOECONOMICS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANKLE BRACHIAL INDEX; ANTICOAGULANTS; ATRIAL FIBRILLATION; CROSS-SECTIONAL STUDIES; FEMALE; HEALTHCARE DISPARITIES; HUMANS; ITALY; MALE; MEDICATION ADHERENCE; MIDDLE AGED; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 84911953188     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-014-1166-4     Document Type: Erratum

References (53)

1. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285:2370–2375
2. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, Seward JB, Tsang TS (2006) Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 114:119–125
3. Ringborg A, Nieuwlaat R, Lindgren P, Jönsson B, Fidan D, Maggioni AP, Lopez-Sendon J, Stepinska J, Cokkinos DV, Crijns HJ (2008) Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation. Europace 10:403–411
4. Marijon E, Le Heuzey JY, Connolly S, Yang S, Pogue J, Brueckmann M, Eikelboom JW, Themeles E, Ezekowitz MD, Wallentin L, Yusuf S (2013) Causes of death and influencing factors in patients with atrial fibrillation: a competing risk analysis from the randomized evaluation of long-term anticoagulant therapy study. Circulation 128:2192–2201
5. Violi F, Davi G, Hiatt W, Lip GY, Corazza GR, Perticone F, Proietti M, Pignatelli P, Vestri AR, Basili S (2013) Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy. J Am Coll Cardiol 62:2255–2256
6. Polimeni L, Perri L, Saliola M, Basili S, Violi F (2010) The risk of myocardial infarction in patients with atrial fibrillation: an unresolved issue. Intern Emerg Med 5:91–94
7. Violi F, Lip GY, Basili S (2012) Peripheral artery disease and atrial fibrillation: a potentially dangerous combination. Intern Emerg Med 7:213–218
8. Buccelletti F, Di Somma S, Galante A, Pugliese F, Alegiani F, Bertazzoni G, Silveri NG, Legramante JM, Franceschi F (2011) Disparities in management of new-onset atrial fibrillation in the emergency department despite adherence to the current guidelines: data from a large metropolitan area. Intern Emerg Med 6:149–156
9. Polimeni L, Perri L, Saliola M, Basili S, Violi F (2010) The risk of myocardial infarction in patients with atrial fibrillation: an unresolved issue. Intern Emerg Med 5:91–94
10. Manina G, Agnelli G, Becattini C, Zingarini G, Paciaroni M (2014) 96 hours ECG monitoring for patients with ischemic cryptogenic stroke or transient ischaemic attack. Intern Emerg Med 9:65–67
11. American College of Cardiology Foundation, American Heart Association, European Society of Cardiology, Heart Rhythm Society, Wann LS, Curtis AB, Ellenbogen KA et al (2013) Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation 127:1916–1926
12. Prisco D, Cenci C, Silvestri E, Emmi G, Barnini T, Tamburini C (2012) The risk stratification in atrial fibrillation. Intern Emerg Med 7(Suppl 3):S233–S240
13. De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, Baigent C, Huber K, Jespersen J, Kristensen SD, Lip GY, Morais J, Rasmussen LH, Siegbahn A, Verheugt FW, Weitz JI, Coordinating Committee (2012) New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis—Task Force on Anticoagulants in Heart Disease position paper. J Am Coll Cardiol 59:1413–1425
14. Coccheri S, Orlando D (2013) New oral anticoagulants in atrial fibrillation: a reappraisal of trial results looking at absolute figures. Intern Emerg Med 8:115–122
15. Heidenreich PA (2004) Patient adherence: the next frontier in quality improvement. Am J Med 117:130–132
16. Ho PM, Bryson CL, Rumsfeld JS (2009) Medication adherence: its importance in cardiovascular outcomes. Circulation 119:3028–3035
17. Yeaw J, Benner JS, Walt JG, Sian S, Smith DB (2009) Comparing adherence and persistence across 6 chronic medication classes. J Manag Care Pharm 15:728–740
18. Cutler DM, Everett W (2010) Thinking outside the pillbox–medication adherence as a priority for health care reform. N Engl J Med 362:1553–1555
19. World Health Organization. Adherence to long-term therapies: evidence for action. http://www.who.int/chp/knowledge/publications/adherence_report/en/Accessed November 28, 2013
20. Lee SK, Kang BY, Kim HG, Son YJ (2013) Predictors of medication adherence in elderly patients with chronic diseases using support vector machine models. Health Inform Res 19:33–41
21. Gazmararian JA, Kripalani S, Miller MJ, Echt KV, Ren J, Rask K (2006) Factors associated with medication refill adherence in cardiovascular-related diseases: a focus on health literacy. J Gen Intern Med 21:1215–1221
22. Kirchhof P, Ammentorp B, Darius H, De Caterina R, Le Heuzey JY, Schilling RJ, Schmitt J, Zamorano JL (2014) Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboembolic events—European Registry in Atrial Fibrillation (PREFER in AF). Europace 16:6–14
23. Marcucci M, Iorio A, Nobili A, Tettamanti M, Pasina L, Marengoni A, Salerno F, Corrao S, Mannucci PM, REPOSI Investigators (2010) Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards. Eur J Intern Med 21:516–523
24. Gussoni G, Di Pasquale G, Vescovo G, Gulizia M, Mathieu G, Scherillo M, Panuccio D, Lucci D, Nozzoli C, Fabbri G, Colombo F, Riva L, Baldo CI, Maggioni AP, Mazzone A, ATA-AF Steering Committee and Investigators (2013) Decision making for oral anticoagulants in atrial fibrillation: the ATA-AF study. Eur J Intern Med 24:324–332
25. Hess PL, Kim S, Piccini JP, Allen LA, Ansell JE, Chang P, Freeman JV, Gersh BJ, Kowey PR, Mahaffey KW, Thomas L, Peterson ED, Fonarow GC (2013) Use of evidence-based cardiac prevention therapy among outpatients with atrial fibrillation. Am J Med 126:625–632
26. Connolly SJ, Eikelboom J, Joyner C et al (2011) Apixaban in patients with atrial fibrillation. N Engl J Med 364:806–817
27. Italian National Institute of Statistics. Report on income and living conditions. www.istat.it/it/files/2012/12/stat_10_12_2012e.pdf Accessed November 28 2013
28. Wann LS, Curtis AB, January CT et al (2011) 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 123:104–123
29. Mancia G, De Backer G, Dominiczak A et al (2007) 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25:1105–1187
30. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 106:3143–3421
31. American Diabetes Association (2009) Standards of medical care in diabetes—2009. Diabetes Care 32(Suppl 1):S13–S61
32. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C, American Heart Association, National Heart, Lung, and Blood Institute (2004) Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation 109:433–438 for the Conference Participants
33. Dickstein K, Cohen-Solal A, Filippatos G et al (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the heart failure association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29:2388–2442
34. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor based approach: the euro heart survey on atrial fibrillation. Chest 137:263–272
35. Aboyans V, Criqui MH, Abraham P et al (2012) Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation 126:2890–2909
36. Grenon SM, Gagnon J, Hsiang Yb (2009) Video in clinical medicine ankle-brachial index for assessment of peripheral arterial disease. N Engl J Med 361:e40
37. Singer DE, Albers GW, Dalen JE, Fang MC, Go AS, Halperin JL, Lip GY, Manning WJ, American College of Chest Physicians (2008) Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133:546S–592S
38. Nobili A, Marengoni A, Tettamanti M, Salerno F, Pasina L, Franchi C, Iorio A, Marcucci M, Corrao S, Licata G, Mannucci PM (2011) Association between clusters of diseases and polypharmacy in hospitalized elderly patients: results from the REPOSI study. Eur J Intern Med 22:597–602
39. Shalansky SJ, Levy AR, Ignaszewski AP (2004) Self-reported Morisky score for identifying nonadherence with cardiovascular medications. Ann Pharmacother 38:1363–1368
40. Morisky DE, Green LW, Levine DM (1986) Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 24:67–74
41. Ferro D, Loffredo L, Polimeni L, Violi F (2007) Underuse of oral anticoagulants in patients with non valvular atrial fibrillation in Italy. Intern Emerg Med 2:24–28
42. Nieuwlaat R, Olsson SB, Lip GY, Camm AJ, Breithardt G, Capucci A, Meeder JG, Prins MH, Lévy S, Crijns HJ, Euro Heart Survey Investigators (2007) Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation. Am Heart J 153:1006–1012
43. Brandes A, Overgaard M, Plauborg L, Dehlendorff C, Lyck F, Peulicke J, Poulsen SV, Husted S (2013) Guideline adherence of antithrombotic treatment initiated by general practitioners in patients with non valvular atrial fibrillation: a Danish survey. Clin Cardiol 36:427–432
44. Nobili A, Licata G, Salerno F, Pasina L, Tettamanti M, Franchi C, De Vittorio L, Marengoni A, Corrao S, Iorio A, Marcucci M, Mannucci PM, SIMI Investigators (2011) Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study. Eur J Clin Pharmacol 67:507–519
45. Opondo D, Eslami S, Visscher S, de Rooij SE, Verheij R, Korevaar JC, Abu-Hanna A (2012) Inappropriateness of medication prescriptions to elderly patients in the primary care setting: a systematic review. PLoS One 7:e43617
46. Gallagher P, Barry P, O’Mahony D (2007) Inappropriate prescribing in the elderly. J Clin Pharm Ther 32:113–121
47. Steinberg BA, Kim S, Thomas L, Fonarow GC, Hylek E, Ansell J, Go AS, Chang P, Kowey P, Gersh BJ, Mahaffey KW, Singer DE, Piccini JP, Peterson ED; on behalf of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Investigators and Patients (2014) Lack of Concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF) Registry. Circulation doi:10.1161/CIRCULATIONAHA.114.008643
48. Gross CP, Vogel EW, Dhond AJ, Marple CB, Edwards RA, Hauch O, Demers EA, Ezekowitz M (2003) Factors influencing physicians’ reported use of anticoagulation therapy in nonvalvular atrial fibrillation: a cross-sectional survey. Clin Ther 25:1750–1764
49. Di Minno A, Spadarella G, Tufano A, Prisco D, Di Minno G (2014) Ensuring medication adherence with direct oral anticoagulant drugs: lessons from adherence with vitamin K antagonists (VKAs). Thromb Res 133:699–704
50. Italian Official Parliament Website, Chamber of Deputies Official Documentshttp://nuovo.camera.it/_dati/leg16/lavori/documentiparlamentari/indiceetesti/022bis/010/INTERO.pdf Accessed April 29, 2014
51. January CT, Wann LS, Alpert JS, Calkins H, Cleveland JC Jr, Cigarroa JE, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW (2014) 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol. doi:10.1016/j.jacc.2014.03.022
52. Reinecke H, Engelbertz C, Schäbitz WR (2013) Preventing stroke in patients with chronic kidney disease and atrial fibrillation: benefit and risks of old and new oral anticoagulants. Stroke 44:2935–2941
53. Oldgren J, Healey JS, Ezekowitz M, Commerford P, Avezum A, Pais P, Zhu J, Jansky P, Sigamani A, Morillo CA, Liu L, Damasceno A, Grinvalds A, Nakamya J, Reilly PA, Keltai K, Van Gelder IC, Yusufali AH, Watanabe E, Wallentin L, Connolly SJ, Yusuf S, RE-LY Atrial Fibrillation Registry Investigators (2014) Variations in cause and management of atrial fibrillation in a prospective registry of 15 400 emergency department patients in 46 countries: The RE-LY Atrial Fibrillation Registry. Circulation 129:1568–1576